Editorial: The evolving paradigms and treatments for primary biliary cholangitis
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17779 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Raj Vuppalanchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Cholangitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
LINKED CONTENT This article is linked to Mayo et al papers. To view these articles, visit https://doi.org/10.1111/apt.17755 and https://doi.org/10.1111/apt.17798
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Liver Institute Northwest, Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA.
ORCID-Profile: Raj Vuppalanchi
Zitieren
APA
Vuppalanchi, R., & Kowdley, K. V. (2024). Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17779
Vancouver
Vuppalanchi R, Kowdley KV. Editorial: The evolving paradigms and treatments for primary biliary cholangitis. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17779
BibTeX
@article{Vuppalanchi2024,
author = {Vuppalanchi, Raj and Kowdley, Kris V},
title = {Editorial: The evolving paradigms and treatments for primary biliary cholangitis},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17779}
}
EUVIMED